Stock Scorer

Mesa Laboratories Inc (MLAB) · Insider trading

What Mesa Laboratories's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.

Bought, 12 months
$1.35M
4 insiders, 5 trades
Sold, 12 months
$1.57M
4 insiders, 16% under a plan
Net, 12 months
−$215,725
bought less sold
Latest filing
2026-08-17
filings read to 2026-10-19

Bought and sold at the market, by month

Two years. Purchases above the line, sales below, in dollars.

2025-01 2025-03: $2.60M sold 2025-06: $296,507 sold 2025-07 2026-01 2026-03: $452,076 bought 2026-06: $770,122 sold 2026-07 2026-08: $902,411 bought 2026-08: $800,090 sold
Bought Sold Largest month: $2.60M

Who traded, two years

InsiderBoughtSold TradesLast tradeHolds after
Owens Gary MPresident and CEO – $3.36M 4 2025-06-16 45,824
Kadia SiddharthaPresident and CEO $800,090 – 1 2026-08-13 –
Sullivan John JamesDirector – $800,090 1 2026-08-13 17,834
Sakys JohnCFO – $439,221 3 2026-06-22 19,785
Archbold Brian DavidSVP Operations – $387,584 3 2026-06-22 6,377
Ladiwala Shiraz ShabanaliDirector $252,805 – 1 2026-03-10 8,523
Tripeny R TonyDirector $202,261 – 2 2026-08-13 6,298
Capone Mark ChristopherDirector $99,331 – 1 2026-03-10 3,429
Crennen Lyndsey ElizabethCAO – $51,509 2 2026-06-22 2,020

Open-market purchases and sales

Newest first. “Plan” marks a trade made under a 10b5-1 plan set up in advance.

DateInsiderTradeShares PriceValueHolds afterFiling
2026-08-13 Tripeny R TonyDirector Buy 900 113.69 $102,321 6,298 Form 4
2026-08-13 Kadia SiddharthaPresident and CEO Buyindirect 7,093 112.80 $800,090 7,093 Form 4
2026-08-13 Sullivan John JamesDirector Sale 7,093 112.80 $800,090 17,834 Form 4
2026-06-22 Sakys JohnCFO Sale 2,827 89.50 $253,016 19,785 Form 4
2026-06-22 Archbold Brian DavidSVP Operations Sale 2,516 89.50 $225,182 6,377 Form 4
2026-06-22 Crennen Lyndsey ElizabethCAO Sale 442 89.50 $39,559 2,020 Form 4
2026-06-16 Sakys JohnCFO Saleplan 1,223 101.27 $123,853 16,538 Form 4
2026-06-16 Crennen Lyndsey ElizabethCAO Saleplan 118 101.27 $11,950 1,473 Form 4
2026-06-16 Archbold Brian DavidSVP Operations Saleplan 1,151 101.27 $116,562 3,710 Form 4
2026-03-10 Tripeny R TonyDirector Buy 1,315 76.00 $99,940 5,398 Form 4
2026-03-10 Capone Mark ChristopherDirector Buy 1,301 76.35 $99,331 3,429 Form 4
2026-03-10 Ladiwala Shiraz ShabanaliDirector Buy 3,500 72.23 $252,805 8,523 Form 4
2025-06-16 Sakys JohnCFO Sale 642 97.12 $62,351 12,865 Form 4
2025-06-16 Archbold Brian DavidSVP Operations Sale 472 97.12 $45,841 558 Form 4
2025-06-16 Owens Gary MPresident and CEO Sale 1,939 97.12 $188,316 45,824 Form 4
2025-03-19 Owens Gary MPresident and CEO Saleplan 21,000 123.91 $2.60M 43,337 Form 4
2024-10-29 Owens Gary MPresident and CEO Sale 2,551 111.98 $285,661 43,337 Form 4
2024-10-28 Owens Gary MPresident and CEO Sale 2,518 113.62 $286,095 45,888 Form 4

Grants, exercises and other transactions

Pay, tax and paperwork rather than a choice to trade at the market price. Two years.

34 × option exercise6 × shares withheld for tax4 × grant or award2 × gift
Show them
DateInsiderWhatShares PriceHolds afterFiling
2026-08-15 Sullivan John JamesDirector Option exercise M +2,784 – 20,618 Form 4
2026-08-15 Tripeny R TonyDirector Option exercise M +2,784 – 9,082 Form 4
2026-08-15 Hall ShannonDirector Option exercise M +2,784 – 6,973 Form 4
2026-08-15 Ladiwala Shiraz ShabanaliDirector Option exercise M +3,810 – 12,333 Form 4
2026-08-15 Alltoft Jennifer SadieDirector Option exercise M +2,784 – 7,662 Form 4
2026-08-15 Capone Mark ChristopherDirector Option exercise M +2,784 – 6,213 Form 4
2026-06-18 Sakys JohnCFO Option exercise M +1,036 95.10 17,574 Form 4
2026-06-18 Sakys JohnCFO Option exercise M +2,756 95.10 20,330 Form 4
2026-06-18 Sakys JohnCFO Grant or award A +2,282 95.10 22,612 Form 4
2026-06-18 Archbold Brian DavidSVP Operations Option exercise M +844 95.10 4,554 Form 4
2026-06-18 Archbold Brian DavidSVP Operations Option exercise M +2,480 95.10 7,034 Form 4
2026-06-18 Archbold Brian DavidSVP Operations Grant or award A +1,859 95.10 8,893 Form 4
2026-06-18 Crennen Lyndsey ElizabethCAO Option exercise M +125 95.10 1,598 Form 4
2026-06-18 Crennen Lyndsey ElizabethCAO Option exercise M +233 95.10 1,831 Form 4
2026-06-18 Crennen Lyndsey ElizabethCAO Option exercise M +368 95.10 2,199 Form 4
2026-06-18 Crennen Lyndsey ElizabethCAO Grant or award A +263 95.10 2,462 Form 4
2026-06-15 Sakys JohnCFO Option exercise M +2,717 104.08 17,761 Form 4
2026-06-15 Archbold Brian DavidSVP Operations Option exercise M +2,454 104.08 4,861 Form 4
2025-12-02 Sullivan John JamesDirector Gift G −2,000 – 25,282 Form 4
2025-10-27 Owens Gary MPresident and CEO Option exercise M +11,558 – 64,135 Form 4
2025-08-15 Alltoft Jennifer SadieDirector Option exercise M +1,404 – 4,878 Form 4
2025-08-15 Capone Mark ChristopherDirector Option exercise M +1,404 – 2,128 Form 4
2025-08-15 Tripeny R TonyDirector Option exercise M +1,404 – 4,083 Form 4
2025-08-15 Hall ShannonDirector Option exercise M +1,404 – 4,189 Form 4
2025-08-15 Sullivan John JamesDirector Option exercise M +1,404 – 27,282 Form 4
2025-08-15 Ladiwala Shiraz ShabanaliDirector Option exercise M +1,949 – 5,023 Form 4
2025-06-21 Archbold Brian DavidSVP Operations Option exercise M +844 95.82 2,792 Form 4
2025-06-21 Archbold Brian DavidSVP Operations Shares withheld for tax F −385 95.82 2,407 Form 4
2025-06-21 Sakys JohnCFO Option exercise M +1,036 95.82 15,498 Form 4
2025-06-21 Sakys JohnCFO Shares withheld for tax F −454 95.82 15,044 Form 4
2025-06-21 Owens Gary MPresident and CEO Option exercise M +3,301 95.82 54,022 Form 4
2025-06-21 Owens Gary MPresident and CEO Shares withheld for tax F −1,445 95.82 52,577 Form 4
2025-06-18 Sakys JohnCFO Option exercise M +2,840 92.99 15,705 Form 4
2025-06-18 Sakys JohnCFO Shares withheld for tax F −1,243 92.99 14,462 Form 4
2025-06-18 Archbold Brian DavidSVP Operations Option exercise M +2,556 92.99 3,114 Form 4
2025-06-18 Archbold Brian DavidSVP Operations Shares withheld for tax F −1,166 92.99 1,948 Form 4
2025-06-18 Owens Gary MPresident and CEO Option exercise M +8,707 92.99 54,531 Form 4
2025-06-18 Owens Gary MPresident and CEO Shares withheld for tax F −3,810 92.99 50,721 Form 4
2025-06-15 Sakys JohnCFO Option exercise M +793 – 12,839 Form 4
2025-06-15 Archbold Brian DavidSVP Operations Option exercise M +535 – 535 Form 4
2025-06-15 Archbold Brian DavidSVP Operations Option exercise M +495 – 1,030 Form 4
2025-06-15 Owens Gary MPresident and CEO Option exercise M +2,324 – 43,337 Form 4
2025-06-15 Owens Gary MPresident and CEO Option exercise M +2,102 – 47,763 Form 4
2025-03-19 Owens Gary MPresident and CEO Option exercise M +21,000 122.98 64,337 Form 4
2024-11-19 Sullivan John JamesDirector Gift G −2,000 – 25,878 Form 4
2024-10-27 Owens Gary MPresident and CEO Grant or award A +11,559 – 48,406 Form 4

How to read it

Buy, sale
Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
Plan
A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
Holds after
The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
Value
Shares times the price the form reports, which is often an average over several fills on the day.

Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.

Mesa Laboratories's scores and multiples ›